Background Image
Table of Contents Table of Contents
Previous Page  281 / 492 Next Page
Information
Show Menu
Previous Page 281 / 492 Next Page
Page Background

S22-12

(P)

ENDOSCOPIC BOTULINUM TOXIN INJECTION FOR NEUROPATHIC BLADDER

DYSFUNCTION: IS INTRA-DETRUSOR DELIVERY TRULY HAPPENING?

Fahad ALYAMI, Paul R. BOWLIN, Darius BAGLI, Martin A. KOYLE and Armando J. LORENZO

THE HOSPITAL FOR SICK CHILDREN, UNIVERSITY OF TORONTO, UROLOGY, Toronto, CANADA

PURPOSE

Botulinum neurotoxin A (BoNT/A) treatment has become a viable option for patients with neuropathic bladder

dysfunction (NPBD) who fail medical management. Bladder BoNT/A injection mechanism of action is thought to be

mediated by chemodenervation of the bladder muscle. Intra-detrusor (ID) and submucosal (SM) injections techniques

has been described. By creating a SM bleb, visual confirmation of insertion depth provides assurance, in contrast to the

ID delivery, which relies solely on estimated depth of injection. In the present study we describe concurrent ultrasound

(US) assessment at the time of BoNT/A bladder injection and correlate sonographic with endoscopic findings.

MATERIAL AND METHODS

Between January and May 2014 we performed cystoscopy and BoNT/A injection with US surveillance in a total of 8

patients with NPBD who were on maintenance BoNT/A program. All procedures were done under general anesthesia, by

one surgeon, and trans-abdominal US was performed. When feasible, we employed the US images to determine depth

and position of the injection, segregated based on the surgeon's impression of a SM and the ID delivery by endoscopy

(blinded to findings on US). We only included data for injection sites with visualization on both modalities.

RESULTS

We included 8 patients with an age range of 5-12 years. There were no reported complications and all patients reported

stable response on follow-up. We confirmed the injections site accurately with US in 39/40 (97%) and 5/23 (22%) in

the SM and ID space respectively. No cases of intra-peritoneal delivery were encountered.

CONCLUSIONS

This study demonstrates that trans-abdominal US-guided bladder BoNT/A injection may provide additional information

regarding depth. By US evaluation, it appears that SM delivery is reliable based on visual cues, whilst ID attempts often

result in delivery outside of the detrusor muscle. If accurate ID delivery is preferred, intra-operative US provides a

novel, non-invasive way of obtaining real-time feedback.